Literature DB >> 11437629

Pregnancy: success and failure within the Th1/Th2/Th3 paradigm.

R Raghupathy1.   

Abstract

Evidence from studies on murine and human pregnancy points to a strong association between maternal Th2-type immunity and successful pregnancy on the one hand and between Th1-type immune reactivity and pregnancy loss on the other. While there is a paucity of data from human pregnancy indicating that Th1-type immune effectors actually lead to pregnancy, it is difficult to ignore the compelling evidence linking inappropriate Th1-type immunity to pregnancy loss. Th2-type immunity and TGF beta secreted by Th3 cells may play protective roles during pregnancy, hence the nexus between a Th2/Th3 shift and successful pregnancy. This paper examines these associations and discusses possible mechanisms underlying immunologically mediated pregnancy failure. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437629     DOI: 10.1006/smim.2001.0316

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  66 in total

1.  Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells.

Authors:  G P Sacks; C W G Redman; I L Sargent
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

2.  Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants.

Authors:  Nefertiti C dupont; Kehui Wang; Pathik D Wadhwa; Jennifer F Culhane; Edward L Nelson
Journal:  J Reprod Immunol       Date:  2005-08       Impact factor: 4.054

3.  The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance.

Authors:  Francesca D'Addio; Leonardo V Riella; Bechara G Mfarrej; Lola Chabtini; La Tonya Adams; Melissa Yeung; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Indira Guleria
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

Review 4.  TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?

Authors:  V Toder; A Fein; H Carp; A Torchinsky
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

Review 5.  TH17 cells in human recurrent pregnancy loss and pre-eclampsia.

Authors:  Binqing Fu; Zhigang Tian; Haiming Wei
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

6.  Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Authors:  Seth P Harris; Melissa T Hines; Robert H Mealey; Debra C Alperin; Stephen A Hines
Journal:  Vet Immunol Immunopathol       Date:  2011-03-21       Impact factor: 2.046

7.  Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF.

Authors:  Jayakumar S Poovassery; Demba Sarr; Geoffrey Smith; Tamas Nagy; Julie M Moore
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

8.  Porphyromonas gingivalis infection in pregnant mice is associated with placental dissemination, an increase in the placental Th1/Th2 cytokine ratio, and fetal growth restriction.

Authors:  Dongming Lin; Mary Alice Smith; John Elter; Catherine Champagne; Christine Lynn Downey; James Beck; Steven Offenbacher
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Nuclear translocation of nuclear factor Kappa B in first trimester deciduas and chorionic villi in early spontaneous miscarriage women.

Authors:  Li-Qin Wang; Xue-Wen Yu; Chun-Fang Yan; Xiang Wang
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

10.  The CXCL12/CXCR4 axis is involved in the maintenance of Th2 bias at the maternal/fetal interface in early human pregnancy.

Authors:  Hai-Lan Piao; Yu Tao; Rui Zhu; Song-Cun Wang; Chuan-Ling Tang; Qiang Fu; Mei-Rong Du; Da-Jin Li
Journal:  Cell Mol Immunol       Date:  2012-08-13       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.